• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体后皮质切除术联合内界膜剥除术治疗非牵拉性糖尿病性黄斑水肿

Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Nontractional Diabetic Macular Edema.

作者信息

Ulrich Jan Niklas

机构信息

Department of Ophthalmology, University of North Carolina at Chapel Hill, United States.

出版信息

Open Ophthalmol J. 2017 Jan 31;11:5-10. doi: 10.2174/1874364101711010005. eCollection 2017.

DOI:10.2174/1874364101711010005
PMID:28567164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5420191/
Abstract

BACKGROUND

Diabetes mellitus remains the leading cause of blindness among working age Americans with diabetic macular edema being the most common cause for moderate and severe vision loss.

OBJECTIVE

To investigate the anatomical and visual benefits of pars plana vitrectomy with inner limiting membrane peeling in patients with nontractional diabetic macular edema as well as correlation of integrity of outer retinal layers on spectral domain optical coherence tomography to visual outcomes.

METHODS

We retrospectively reviewed the charts of 42 diabetic patients that underwent vitrectomy with internal limiting membrane peeling for nontractional diabetic macula edema. The integrity of outer retinal layers was evaluated and preoperative central macular thickness and visual acuity were compared with data at 1 month, 3 months and 6 months postoperatively. The student t-test was used to compare the groups.

RESULTS

31 eyes were included. While no differences were seen at 1 and 3 months, there was significant improvement of both central macular thickness and visual acuity at the 6 months follow up visit compared to preoperatively (357, 427 microns; p=0.03. 20/49, 20/82; p=0.03) . Patients with intact external limiting membrane and ellipsoid zone had better preoperative vision than patients with outer retinal layer irregularities (20/54, 20/100; p=0.03) and greater visual gains postoperatively (20/33, p<0.001 20/81; p=non-significant).

CONCLUSION

Pars plana vitrectomy with internal limiting membrane peeling can improve retinal anatomy and visual acuity in patients with nontractional diabetic macular edema. Spectral domain optical coherence tomography may help identify patients with potential for visual improvement.

摘要

背景

糖尿病仍然是美国工作年龄人群失明的主要原因,糖尿病性黄斑水肿是中度和重度视力丧失的最常见原因。

目的

探讨在非牵引性糖尿病性黄斑水肿患者中行玻璃体切割联合内界膜剥除术的解剖学和视觉益处,以及光谱域光学相干断层扫描检测的视网膜外层完整性与视觉预后的相关性。

方法

我们回顾性分析了42例因非牵引性糖尿病性黄斑水肿接受玻璃体切割联合内界膜剥除术的糖尿病患者的病历。评估视网膜外层的完整性,并将术前中心黄斑厚度和视力与术后1个月、3个月和6个月的数据进行比较。采用学生t检验比较各组数据。

结果

纳入31只眼。虽然在术后1个月和3个月时未观察到差异,但与术前相比,在6个月随访时中心黄斑厚度和视力均有显著改善(分别为357、427微米;p = 0.03。视力分别为20/49、20/82;p = 0.03)。外界膜和椭圆体带完整的患者术前视力优于视网膜外层不规则的患者(20/54、20/100;p = 0.03),术后视力提高幅度更大(20/33,p < 0.001;20/81;p无统计学意义)。

结论

玻璃体切割联合内界膜剥除术可改善非牵引性糖尿病性黄斑水肿患者的视网膜解剖结构和视力。光谱域光学相干断层扫描有助于识别视力可能改善的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/554b/5420191/481278fd6929/TOOPHTJ-11-5_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/554b/5420191/481278fd6929/TOOPHTJ-11-5_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/554b/5420191/481278fd6929/TOOPHTJ-11-5_F1.jpg

相似文献

1
Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Nontractional Diabetic Macular Edema.玻璃体后皮质切除术联合内界膜剥除术治疗非牵拉性糖尿病性黄斑水肿
Open Ophthalmol J. 2017 Jan 31;11:5-10. doi: 10.2174/1874364101711010005. eCollection 2017.
2
ILM peeling in nontractional diabetic macular edema: review and metanalysis.非牵引性糖尿病性黄斑水肿的内界膜剥除术:综述与荟萃分析
Int Ophthalmol. 2018 Dec;38(6):2709-2714. doi: 10.1007/s10792-017-0761-6. Epub 2017 Oct 31.
3
Transconjunctival 25-gauge pars plana vitrectomy and internal limiting membrane peeling for chronic macular edema.经结膜25G玻璃体切割联合内界膜剥除术治疗慢性黄斑水肿
Clin Ophthalmol. 2012;6:981-9. doi: 10.2147/OPTH.S33391. Epub 2012 Jul 6.
4
Optic nerve atrophy after vitrectomy with indocyanine green-assisted internal limiting membrane peeling in diffuse diabetic macular edema. Adverse effect of ICG-assisted ILM peeling.吲哚菁绿辅助内界膜剥除玻璃体切割术后弥漫性糖尿病性黄斑水肿的视神经萎缩。吲哚菁绿辅助内界膜剥除的不良影响。
Graefes Arch Clin Exp Ophthalmol. 2004 Dec;242(12):995-9. doi: 10.1007/s00417-004-0864-4. Epub 2004 Jul 17.
5
Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema.玻璃体切除术在非牵引性难治性糖尿病性黄斑水肿中的作用
J Clin Med. 2023 Mar 15;12(6):2297. doi: 10.3390/jcm12062297.
6
The effect of pars plana vitrectomy with internal limiting membrane peeling on the durability of the intravitreal dexamethasone implant in the treatment of diabetic macular edema.玻璃体平坦部玻璃体切除术联合内界膜剥除术对玻璃体内地塞米松植入物治疗糖尿病性黄斑水肿疗效持久性的影响
Am J Ophthalmol Case Rep. 2022 Feb 17;26:101401. doi: 10.1016/j.ajoc.2022.101401. eCollection 2022 Jun.
7
INFLUENCE OF VITRECTOMY SURGERY ON THE INTEGRITY OF OUTER RETINAL LAYERS IN DIABETIC MACULAR EDEMA.玻璃体切除术对糖尿病性黄斑水肿患者视网膜外层完整性的影响
Retina. 2018 Jan;38(1):163-172. doi: 10.1097/IAE.0000000000001519.
8
EFFECT OF INTERNAL LIMITING MEMBRANE PEELING ON LONG-TERM VISUAL OUTCOMES FOR DIABETIC MACULAR EDEMA.内界膜剥除术对糖尿病性黄斑水肿长期视力预后的影响
Retina. 2015 Jul;35(7):1422-8. doi: 10.1097/IAE.0000000000000497.
9
Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.对于无紧张后玻璃体后皮质的难治性糖尿病性黄斑水肿行玻璃体平坦部玻璃体切除术联合内界膜剥除术
Graefes Arch Clin Exp Ophthalmol. 2005 Jan;243(1):20-5. doi: 10.1007/s00417-004-0958-z. Epub 2004 Jul 31.
10
Pars plana vitrectomy and internal limiting membrane peeling for macular oedema secondary to retinal vein occlusion: a pilot study.玻璃体切割术联合内界膜剥除术治疗视网膜静脉阻塞继发黄斑水肿的初步研究
Ann Acad Med Singap. 2007 Apr;36(4):293-7.

引用本文的文献

1
Surgical Management of Diabetic Macular Edema.糖尿病性黄斑水肿的手术治疗。
Curr Diab Rep. 2023 Jun;23(6):119-125. doi: 10.1007/s11892-023-01505-3. Epub 2023 Apr 12.
2
Diabetic Macular Oedema Guidelines: An Australian Perspective.糖尿病性黄斑水肿指南:澳大利亚视角
J Ophthalmol. 2023 Feb 14;2023:6329819. doi: 10.1155/2023/6329819. eCollection 2023.
3
Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy.雷珠单抗预处理在重度增殖性糖尿病视网膜病变伴糖尿病性黄斑水肿的玻璃体切割联合内界膜剥除术中的应用

本文引用的文献

1
Vitrectomy for center-involved diabetic macular edema.玻璃体切除术治疗累及黄斑中心的糖尿病性黄斑水肿。
Clin Ophthalmol. 2016 Apr 26;10:735-42. doi: 10.2147/OPTH.S104906. eCollection 2016.
2
EFFECT OF INTERNAL LIMITING MEMBRANE PEELING ON LONG-TERM VISUAL OUTCOMES FOR DIABETIC MACULAR EDEMA.内界膜剥除术对糖尿病性黄斑水肿长期视力预后的影响
Retina. 2015 Jul;35(7):1422-8. doi: 10.1097/IAE.0000000000000497.
3
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
Diabetes Ther. 2020 Jun;11(6):1397-1406. doi: 10.1007/s13300-020-00822-0. Epub 2020 Apr 30.
4
Efficacy and safety of vitrectomy with internal limiting membrane peeling for diabetic macular edema: a Meta-analysis.玻璃体切除术联合内界膜剥除治疗糖尿病性黄斑水肿的疗效与安全性:一项Meta分析
Int J Ophthalmol. 2018 Nov 18;11(11):1848-1855. doi: 10.18240/ijo.2018.11.18. eCollection 2018.
5
Evaluation of Vitrectomy with Planned Foveal Detachment as Surgical Treatment for Refractory Diabetic Macular Edema with or without Vitreomacular Interface Abnormality.对伴有或不伴有玻璃体黄斑界面异常的难治性糖尿病性黄斑水肿采用计划性黄斑脱离玻璃体切除术作为手术治疗的评估。
J Ophthalmol. 2018 May 7;2018:9246384. doi: 10.1155/2018/9246384. eCollection 2018.
为期三年的随机、假手术对照试验:地塞米松眼内植入物治疗糖尿病性黄斑水肿患者。
Ophthalmology. 2014 Oct;121(10):1904-14. doi: 10.1016/j.ophtha.2014.04.024. Epub 2014 Jun 4.
4
Hyperreflective foci in outer retina predictive of photoreceptor damage and poor vision after vitrectomy for diabetic macular edema.外视网膜的高反射焦点可预测糖尿病性黄斑水肿玻璃体切除术后光感受器损伤和视力不良。
Retina. 2014 Apr;34(4):732-40. doi: 10.1097/IAE.0000000000000005.
5
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.雷珠单抗治疗糖尿病黄斑水肿的长期疗效:两项 III 期临床试验(RISE 和 RIDE)的 36 个月结果。
Ophthalmology. 2013 Oct;120(10):2013-22. doi: 10.1016/j.ophtha.2013.02.034. Epub 2013 May 22.
6
Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema.地塞米松眼内植入物联合激光光凝治疗弥漫性糖尿病性黄斑水肿。
Ophthalmology. 2013 Sep;120(9):1843-51. doi: 10.1016/j.ophtha.2013.02.018. Epub 2013 May 22.
7
Fluocinolone acetonide intravitreal implant (Iluvien®): in diabetic macular oedema.氟轻松玻璃体内植入剂(Iluvien®):治疗糖尿病性黄斑水肿。
Drugs. 2013 Feb;73(2):187-93. doi: 10.1007/s40265-013-0010-x.
8
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results.玻璃体腔内雷珠单抗治疗糖尿病黄斑水肿:即刻与延迟激光治疗的 3 年随机试验结果。
Ophthalmology. 2012 Nov;119(11):2312-8. doi: 10.1016/j.ophtha.2012.08.022. Epub 2012 Sep 19.
9
One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.《da Vinci 研究:VEGF 陷阱眼内注射治疗糖尿病黄斑水肿的一年结果》。
Ophthalmology. 2012 Aug;119(8):1658-65. doi: 10.1016/j.ophtha.2012.02.010. Epub 2012 Apr 24.
10
External limiting membrane as a predictor of visual improvement in diabetic macular edema after pars plana vitrectomy.外节膜作为预测糖尿病黄斑水肿患者行玻璃体切割术后视力改善的指标。
Graefes Arch Clin Exp Ophthalmol. 2012 Oct;250(10):1415-20. doi: 10.1007/s00417-012-1968-x. Epub 2012 Feb 23.